Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Iris Pharma | INDUSTRY |
| Axial Biotech, Inc | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to determine the incidence and characteristics of eyelid inflammatory disorders during general ophthalmological consultations and to demonstrate association between palpebral pathologies and ocular surface pathologies.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Outpatients attending general ophthalmologic consultation |
|
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Incidence of eyelid disorders in general ophthalmological practice |
| Day 1 |
| Measure | Description | Time Frame |
|---|---|---|
| Association between palpebral pathologies and ocular surface pathologies | To describe association between palpebral pathologies and ocular surface pathologies | Day 1 |
| Impact of eyelid disorder on patient's daily life |
Not provided
Inclusion Criteria:
Not provided
Not provided
Not provided
Patients will be eligible for inclusion if all these criteria are respected:
Not provided
| Name | Affiliation | Role |
|---|---|---|
| José Manuel Benitez del Castillo, Professor | USIO, Departamento de Oftalmología, Hospital Clínico San Carlos, 28040 Madrid, Spain | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Consultation office | Heidelberg | 69121 | Germany | |||
| USIO Departamento de Oftalmologia Hospital Clínico San Carlos |
Not provided
| ID | Term |
|---|---|
| D000080343 | Meibomian Gland Dysfunction |
| ID | Term |
|---|---|
| D005141 | Eyelid Diseases |
| D005128 | Eye Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Consequences on vision, on daily life activities/work, on leisure, on contact lens wearing, on emotions, on sleeping,
| Day 1 |
| Current recommended strategy to treat eyelids disorders | Description of recommended strategy | Day 1 |
| Madrid |
| 28040 |
| Spain |